PRESS RELEASES
2022-05-25 11:30
Lipum participates at Redeye Growth Day 2022
Redeye Growth Day takes place on June 2 in Stockholm and will be a combination of a digital platform and live presentations. Lipum is "In Focus"...
2022-05-18 08:30
Lipum AB – interim report for the period January-March 2022
CEO Einar Pontén comments: “More progress was made in the preparations ahead of clinical trials. In parallel, and in accordance with our strategy...
2022-05-13 13:15
Lipum initiates collaboration with Pelago Bioscience
Pelago Bioscience AB is a fast-growing Swedish company, based in Solna, with bioanalytical expertise and services for drug discovery and development. Pelago...
2022-05-05 17:10
Lipum in consortium being granted research funding by KKS
Lipum is member of the consortium together with both industry and academic partners. The project is led by the Cardiovascular Research Centre (CVRC) at...
2022-04-07 09:00
Lipum abstract accepted for EULAR 2022
The aim of Annual European Congress of Rheumatology EULAR 2022 is to provide a forum of the highest standard for scientific (both clinical and basic)...
2022-03-25 06:00
Lipum AB – Year-end report 2021
CEO Einar Pontén comments: “The last quarter of the year was largely characterized by the fact that we completed activities that constitute...
2022-03-09 08:30
Lipum has entered a partnership with QPS Netherlands B.V. for its first clinical trial with SOL-116
Lipum AB and QPS The Netherlands BV are pleased to announce a collaboration on the first-in-human study of SOL-116 with the aim of becoming a new treatment...
2022-02-24 08:45
Lipum’s GMP production of SOL-116 successful
Lipum's biological drug candidate SOL-116 has successfully been manufactured under the regulations that apply to Good Manufacturing Practice (GMP). The...
2022-02-02 13:00
Lipum recruits scientist
Lipum's development work is in an intensive phase and an initial clinical phase 1 study is being prepared. Preclinical studies have previously shown promising...
2021-12-22 13:00
Lipum AB - report from extra general meeting
Decision on the introduction of incentive programs for employees and consultants The meeting resolved that the program shall consist of a maximum of 72,500...